Plain-English translation of NCT07582211 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a device called bilevel positive airway pressure (BPAP)—a special breathing mask that gently pushes air into the lungs—can help children who are having a severe asthma attack and aren't getting better with standard rescue medications. Some children will receive the BPAP mask plus the usual continuous asthma inhaler medicine, while others will receive just the inhaler medicine alone. The research team wants to see if adding this breathing support helps children feel better faster and breathe more easily.
Many children come to the emergency department with severe asthma attacks that don't improve with first-line treatments like inhalers and steroids. Doctors need to know whether this breathing mask can help these children avoid admission to the intensive care unit or help them get better more quickly.
If you join this study, you will be randomly assigned to one of two groups. One group will receive the breathing mask (BPAP) along with continuous albuterol inhaler medicine for about 2 hours, while the other group will receive just the continuous albuterol inhaler medicine. Trained respiratory therapists or nurses will place the mask on your face and adjust the settings as needed. After the 2-hour period, your medical team will decide what additional care you need based on how you're doing. The study mainly takes place during your emergency department visit.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
United States